Skip to main content
Clinical Trials/NCT02037178
NCT02037178
Completed
Not Applicable

Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study

Centre Hospitalier Universitaire de Nīmes2 sites in 1 country300 target enrollmentOctober 28, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Obliterative Arteriopathy
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
300
Locations
2
Primary Endpoint
Largest external antero-posterior diameter of the sub-renal abdominal aorta (mm)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The main objective of this study is to evaluate the inter-observer concordance when measuring the maximum value of the external antero-posterior diameter of the sub-renal aorta (both cross-sectional and longitudinal ultrasound views are measured). The first measure is made by a general practitioner in private practice; second reading are made by an expert in vascular medicine.

Detailed Description

The secondary objectives of this study are: A. To assess the prevalence of Abdominal Aortic Aneurysm (AAA) detected by ultrasound measurement of the anterior and posterior longitudinal outer diameter of the sub-renal abdominal aorta in a high cardiovascular risk population consulting with general practitioners (defined according to recommendations stated by the French Society of Vascular Medicine). B. To assess the prevalence of Peripheral Obliterative Arteriopathy of the Legs (POAL) by measuring the Systolic Pressure Index (SPI) at the toe (ratio of arterial pressure in upper limbs versus lower limbs). Measures are made by a general practitioner in the same population. C. To assess the quality and interpretability of ultrasound recordings and ultrasound acquistion failure rate. These second measures are made by an expert in vascular medecine. This evaluation with use a 3-level scale: 1. appropriate image was not obtained or not recognized expert - uninterpretable 2. poor image quality - interpretable 3. image of good or very good quality - interpretable D. To calculate the impact of risk cofactors such as hypertension , smoking, age and family history among patients diagnosed with AAA. E. Evaluation of general practitioner training from a qualitative and quantitative point of view after 4 h of training organized by Dr. Bobbià .

Registry
clinicaltrials.gov
Start Date
October 28, 2014
End Date
December 20, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient falls into one of the following 4 groups as defined by the French Society of Vascular Medecin (2006):
  • (1) Men and women 60-75 years of age who are active smokers or ex-smokers
  • (2) Men over 75 years of age
  • (3) Women over 75 years of age who smoke and who have known hypertension
  • (4) Men and women over 50 years of age with a family history of aneurysm of the abdominal aorta

Exclusion Criteria

  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The subject has an allergy to the gel used for ultrasound examination.

Outcomes

Primary Outcomes

Largest external antero-posterior diameter of the sub-renal abdominal aorta (mm)

Time Frame: Baseline (day 0)

Measures made using both cross-sectional and longitudinal ultrasounds.

Secondary Outcomes

  • Largest external antero-posterior diameter of the sub-renal abdominal aorta (mm) : second interpretation of echographic material by a second expert(maximum of three months)
  • SPI at the toe (mmHg)(baseline (Day 0))
  • Ultrasound quality as assessed by the second expert(maximum of three months)

Study Sites (2)

Loading locations...

Similar Trials